Andrew Tam

Icahn School of Medicine at Mount Sinai

Papers

2

Total Citations

24

H-Index

2

About

Andrew Tam is a leading figure in urologic oncology, with a focused expertise in the surgical management of renal cell carcinoma. His research is centered on advancing minimally-invasive techniques, particularly robotic partial nephrectomy (RPN), to improve patient outcomes. Dr. Tam’s most influential work, "Robotic partial nephrectomy: The current status" (2020, 20 citations), provides a comprehensive review of evolving surgical techniques and their impact on perioperative, functional, and oncologic results, establishing a benchmark for the field. He further contributes to evidence-based practice through rigorous comparative studies, such as his propensity-score matched analysis of open versus minimally-invasive partial nephrectomy (2022, 4 citations), which clarifies patterns of recurrence and long-term oncological outcomes. By systematically evaluating surgical innovations, Dr. Tam helps guide clinical decision-making, balancing the benefits of robotic approaches with the imperative of cancer control. His work is essential reading for surgeons and researchers seeking to understand the current landscape and future directions of nephron-sparing surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
24
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Robotic partial nephrectomy: The current status
20 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago